{
  "DOI": "10.1038/s41431-021-00878-x",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00878-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eIn childhood cancer, the frequency of cancer-associated germline variants and their inheritance patterns are not thoroughly investigated. Moreover, the identification of children carrying a genetic predisposition by clinical means remains challenging. In this single-center study, we performed trio whole-exome sequencing and comprehensive clinical evaluation of a prospectively enrolled cohort of 160 children with cancer and their parents. We identified in 11/160 patients a pathogenic germline variant predisposing to cancer and a further eleven patients carried a prioritized VUS with a strong association to the cancerogenesis of the patient. Through clinical screening, 51 patients (31.3%) were identified as suspicious for an underlying cancer predisposition syndrome (CPS), but only in ten of those patients a pathogenic variant could be identified. In contrast, one patient with a classical CPS and ten patients with prioritized VUS were classified as unremarkable in the clinical work-up. Taken together, a monogenetic causative variant was detected in 13.8% of our patients using WES. Nevertheless, the still unclarified clinical suspicious cases emphasize the need to consider other genetic mechanisms including new target genes, structural variants, or polygenic interactions not previously associated with cancer predisposition.\u003c/jats:p\u003e",
  "alternative-id": [
    "878"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 January 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "5 March 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "25 March 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "12 April 2021"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wagener",
      "given": "Rabea",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Taeubner",
      "given": "Julia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Walter",
      "given": "Carolin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yasin",
      "given": "Layal",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alzoubi",
      "given": "Deya",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bartenhagen",
      "given": "Christoph",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Attarbaschi",
      "given": "Andishe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Classen",
      "given": "Carl-Friedrich",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3072-6772",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kontny",
      "given": "Udo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hauer",
      "given": "Julia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fischer",
      "given": "Ute",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dugas",
      "given": "Martin",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4577-0503",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kuhlen",
      "given": "Michaela",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6121-4737",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Borkhardt",
      "given": "Arndt",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brozou",
      "given": "Triantafyllia",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ],
    "date-time": "2021-04-12T02:02:43Z",
    "timestamp": 1618192963000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        8,
        25
      ]
    ],
    "date-time": "2021-08-25T01:05:40Z",
    "timestamp": 1629853540000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T07:35:23Z",
    "timestamp": 1714548923288
  },
  "is-referenced-by-count": 33,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "8",
  "issued": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2021,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            4,
            12
          ]
        ],
        "date-time": "2021-04-12T00:00:00Z",
        "timestamp": 1618185600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            4,
            12
          ]
        ],
        "date-time": "2021-04-12T00:00:00Z",
        "timestamp": 1618185600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00878-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00878-x",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00878-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1301-1311",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJMoa1508054",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2336",
      "journal-title": "N Engl J Med",
      "key": "878_CR1",
      "unstructured": "Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373:2336–46.",
      "volume": "373",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature25480",
      "author": "SN Gröbner",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Nature.",
      "key": "878_CR2",
      "unstructured": "Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555:321–7.",
      "volume": "555",
      "year": "2018"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-1725",
      "author": "IJ Diets",
      "doi-asserted-by": "publisher",
      "first-page": "1594",
      "journal-title": "Clin Cancer Res",
      "key": "878_CR3",
      "unstructured": "Diets IJ, Waanders E, Ligtenberg MJ, van Bladel DAG, Kamping EJ, Hoogerbrugge PM, et al. High yield of pathogenic germline mutations causative or likely causative of the cancer phenotype in selected children with cancer. Clin Cancer Res. 2018;24:1594–603.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41467-020-16067-1",
      "author": "S Akhavanfard",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "878_CR4",
      "unstructured": "Akhavanfard S, Padmanabhan R, Yehia L, Cheng F, Eng C. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. Nat Commun. 2020;11:2206.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ejmg.2016.01.008",
      "author": "MCJ Jongmans",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "journal-title": "Eur J Med Genet",
      "key": "878_CR5",
      "unstructured": "Jongmans MCJ, Loeffen JLCM, Waanders E, Hoogerbrugge PM, Ligtenberg MJL, Kuiper RP, et al. Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool. Eur J Med Genet. 2016;59:116–25.",
      "volume": "59",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ajmg.a.38142",
      "author": "T Ripperger",
      "doi-asserted-by": "publisher",
      "first-page": "1017",
      "journal-title": "Am J Med Genet A",
      "key": "878_CR6",
      "unstructured": "Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the cancer predisposition working group of the society for pediatric oncology and hematology. Am J Med Genet A. 2017;173:1017–37.",
      "volume": "173",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pgen.1009231",
      "author": "A Byrjalsen",
      "doi-asserted-by": "publisher",
      "first-page": "e1009231",
      "journal-title": "PLoS Genet",
      "key": "878_CR7",
      "unstructured": "Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, et al. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. PLoS Genet. 2020;16:e1009231.",
      "volume": "16",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s00431-017-2997-6",
      "author": "T Brozou",
      "doi-asserted-by": "publisher",
      "first-page": "53",
      "journal-title": "Eur J Pediatr",
      "key": "878_CR8",
      "unstructured": "Brozou T, Taeubner J, Velleuer E, Dugas M, Wieczorek D, Borkhardt A, et al. Genetic predisposition in children with cancer - affected families’ acceptance of Trio-WES. Eur J Pediatr. 2018;177:53–60.",
      "volume": "177",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "878_CR9",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2018.03.039",
      "author": "K-L Huang",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "journal-title": "Cell.",
      "key": "878_CR10",
      "unstructured": "Huang K-L, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. Cell. 2018;173:355–70.e14.",
      "volume": "173",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/bty649",
      "author": "AD Scott",
      "doi-asserted-by": "publisher",
      "first-page": "865",
      "journal-title": "Bioinformatics.",
      "key": "878_CR11",
      "unstructured": "Scott AD, Huang K-L, Weerasinghe A, Mashl RJ, Gao Q, Martins Rodrigues F, et al. CharGer: clinical characterization of germline variants. Bioinformatics. 2019;35:865–7.",
      "volume": "35",
      "year": "2019"
    },
    {
      "DOI": "10.1101/846089",
      "doi-asserted-by": "crossref",
      "key": "878_CR12",
      "unstructured": "Nakken S, Saveliev V, Hofmann O, Møller P, Myklebost O, Hovig E. Cancer Predisposition Sequencing Reporter (CPSR): a flexible variant report engine for germline screening in cancer [Internet]. Bioinformatics; 2019. Available from: http://biorxiv.org/lookup/doi/10.1101/846089."
    },
    {
      "DOI": "10.1007/s10689-016-9958-5",
      "author": "J Fremerey",
      "doi-asserted-by": "publisher",
      "first-page": "401",
      "journal-title": "Fam Cancer",
      "key": "878_CR13",
      "unstructured": "Fremerey J, Balzer S, Brozou T, Schaper J, Borkhardt A, Kuhlen M. Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome. Fam Cancer. 2017;16:401–5.",
      "volume": "16",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41431-017-0048-4",
      "author": "J Taeubner",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "journal-title": "Eur J Hum Genet",
      "key": "878_CR14",
      "unstructured": "Taeubner J, Brozou T, Qin N, Bartl J, Ginzel S, Schaper J, et al. Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations. Eur J Hum Genet. 2018;26:137–42.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-017-0071-5",
      "author": "J Taeubner",
      "doi-asserted-by": "publisher",
      "first-page": "440",
      "journal-title": "Eur J Hum Genet",
      "key": "878_CR15",
      "unstructured": "Taeubner J, Wimmer K, Muleris M, Lascols O, Colas C, Fauth C, et al. Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6. Eur J Hum Genet. 2018;26:440–4.",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41375-019-0459-z",
      "author": "M Lin",
      "doi-asserted-by": "publisher",
      "first-page": "2331",
      "journal-title": "Leukemia.",
      "key": "878_CR16",
      "unstructured": "Lin M, Nebral K, Gertzen CGW, Ganmore I, Haas OA, Bhatia S, et al. JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility. Leukemia. 2019;33:2331–5.",
      "volume": "33",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ng772",
      "author": "M Tartaglia",
      "doi-asserted-by": "publisher",
      "first-page": "465",
      "journal-title": "Nat Genet",
      "key": "878_CR17",
      "unstructured": "Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–8.",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.20005",
      "author": "A Fragale",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Hum Mutat",
      "key": "878_CR18",
      "unstructured": "Fragale A, Tartaglia M, Wu J, Gelb BD. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum Mutat. 2004;23:267–77.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.3390/genes9040216",
      "doi-asserted-by": "crossref",
      "key": "878_CR19",
      "unstructured": "Stella A, Lastella P, Loconte DC, Bukvic N, Varvara D, Patruno M, et al. Accurate classification of NF1 gene variants in 84 Italian patients with Neurofibromatosis Type 1. Genes (Basel). 2018;9:216."
    },
    {
      "DOI": "10.1001/jama.2011.743",
      "author": "V Bonadona",
      "doi-asserted-by": "publisher",
      "first-page": "2304",
      "journal-title": "JAMA.",
      "key": "878_CR20",
      "unstructured": "Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304–10.",
      "volume": "305",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00439-005-0070-4",
      "author": "PP Madsen",
      "doi-asserted-by": "publisher",
      "first-page": "680",
      "journal-title": "Hum Genet",
      "key": "878_CR21",
      "unstructured": "Madsen PP, Kibaek M, Roca X, Sachidanandam R, Krainer AR, Christensen E, et al. Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A\u003eG mutation that causes exon skipping. Hum Genet. 2006;118:680–90.",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.18.01854",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "1305",
      "journal-title": "J Clin Oncol",
      "key": "878_CR22",
      "unstructured": "Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37:1305–15.",
      "volume": "37",
      "year": "2019"
    },
    {
      "DOI": "10.1182/blood-2005-12-5022",
      "author": "MF Rudd",
      "doi-asserted-by": "publisher",
      "first-page": "638",
      "journal-title": "Blood.",
      "key": "878_CR23",
      "unstructured": "Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood. 2006;108:638–44.",
      "volume": "108",
      "year": "2006"
    },
    {
      "DOI": "10.1089/dna.2013.1970",
      "author": "F Han",
      "doi-asserted-by": "publisher",
      "first-page": "329",
      "journal-title": "DNA Cell Biol",
      "key": "878_CR24",
      "unstructured": "Han F, Guo C, Liu L. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol. 2013;32:329–35.",
      "volume": "32",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.canep.2013.03.003",
      "author": "MR Akbari",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "journal-title": "Cancer Epidemiol",
      "key": "878_CR25",
      "unstructured": "Akbari MR, Anderson LN, Buchanan DD, Clendenning M, Jenkins MA, Win AK, et al. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiol. 2013;37:424–7.",
      "volume": "37",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ijc.20239",
      "author": "J Steffen",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "Int J Cancer",
      "key": "878_CR26",
      "unstructured": "Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer. 2004;111:67–71.",
      "volume": "111",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/djm251",
      "author": "E Seemanová",
      "doi-asserted-by": "publisher",
      "first-page": "1875",
      "journal-title": "J Natl Cancer Inst",
      "key": "878_CR27",
      "unstructured": "Seemanová E, Jarolim P, Seeman P, Varon R, Digweed M, Swift M, et al. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst. 2007;99:1875–80.",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.leu.2404285",
      "author": "M Mosor",
      "doi-asserted-by": "publisher",
      "first-page": "1454",
      "journal-title": "Leukemia.",
      "key": "878_CR28",
      "unstructured": "Mosor M, Ziółkowska I, Pernak-Schwarz M, Januszkiewicz-Lewandowska D, Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia. 2006;20:1454–6.",
      "volume": "20",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng1902",
      "author": "S Seal",
      "doi-asserted-by": "publisher",
      "first-page": "1239",
      "journal-title": "Nat Genet",
      "key": "878_CR29",
      "unstructured": "Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006;38:1239–41.",
      "volume": "38",
      "year": "2006"
    },
    {
      "DOI": "10.3390/cancers12040829",
      "author": "J Del Valle",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "journal-title": "Cancers (Basel)",
      "key": "878_CR30",
      "unstructured": "Del Valle J, Rofes P, Moreno-Cabrera JM, López-Dóriga A, Belhadj S, Vargas-Parra G, et al. Exploring the role of mutations in fanconi anemia genes in hereditary cancer patients. Cancers (Basel). 2020;12:829.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature03442",
      "author": "J Falck",
      "doi-asserted-by": "publisher",
      "first-page": "605",
      "journal-title": "Nature.",
      "key": "878_CR31",
      "unstructured": "Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature. 2005;434:605–11.",
      "volume": "434",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng.569",
      "author": "A Meindl",
      "doi-asserted-by": "publisher",
      "first-page": "410",
      "journal-title": "Nat Genet",
      "key": "878_CR32",
      "unstructured": "Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42:410–4.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1002/humu.21625",
      "author": "ER Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Hum Mutat",
      "key": "878_CR33",
      "unstructured": "Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DYH, et al. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat. 2012;33:95–9.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.gde.2010.03.005",
      "author": "RP Kuiper",
      "doi-asserted-by": "publisher",
      "first-page": "282",
      "journal-title": "Curr Opin Genet Dev",
      "key": "878_CR34",
      "unstructured": "Kuiper RP, Ligtenberg MJL, Hoogerbrugge N, Geurts van Kessel A. Germline copy number variation and cancer risk. Curr Opin Genet Dev. 2010;20:282–9.",
      "volume": "20",
      "year": "2010"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00878-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}